Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in: BMC Neurology 1/2017

Open Access 01-12-2017 | Research article

Lower serum uric acid level strongly predict short-term poor functional outcome in acute stroke with normoglycaemia: a cohort study in China

Authors: Shuolin Wu, Yuesong Pan, Ning Zhang, Wang Yong Jun, Chunxue Wang, On Behalf of the Investigators for the Survey on Abnormal Glucose Regulation in Patients With Acute Stroke Across China (ACROSS-China)

Published in: BMC Neurology | Issue 1/2017

Login to get access

Abstract

Background

Conflicting results on the correlation between hyperuricemia and the prognosis of stroke had been reported and the close association between serum uric acid (SUA) and abnormal glycomatabolism might further complicate the assessment of the correlation. We aimed to investigate SUA in predicting the prognosis of acute stroke in different glycometabolism status.

Methods

A total of 2907 patients aged from 18 to 85 (1220 diabetes mellitus (DM), 777 prediabetes and 910 normoglycemia) were selected from the Abnormal Glucose Regulation in Patients with Acute Stroke across China (ACROSS-China) study. The patients were divided into groups according to the SUA quartile as well as decile. The correlations between SUA and the poor outcome (mRS > 2) at discharge were assessed stratified by glucose metabolism status. Multivariate logistic regression was used to analyze the potential risk factors of poor in-hospital outcome of stroke and the risk-adjustment of the correlation between SUA and the prognosis of stroke. P < 0.05 was considered statistically significant.

Results

SUA were divided first as Quartile1 to 4 (Quartile1 < 221 μmol L−1; Quartile2 (221–286) μmol L−1; Quartile3 (286–352) μmol L−1 and Quartile4 > 352 μmol L−1), then as decile1 to 10. In normoglycaemia, SUA quartiles, deciles and continuous SUA concentration were independently significantly associated with poor outcome. Q1 was independently associated with the higher possibility of poor functional outcome (compared to Q4, odds ratios (ORs) with 95% confidential interval (CI) was 3.79 (1.23–8.67) in Q1); Lower level of SUA in DM was also associated with poor functional outcome at discharge compared to the highest level of SUA(Q4)(OR with 95% CI, 2.07 (1.05–4.08)), however, lower SUA level was also related to severer stroke at admission in DM as well as in prediabetes (P < 0.001 in DM and 0.023 in prediabetes) and severer stroke resulted in worse functional outcome at discharge (OR with 95% CI, 12.15 (8.08–18.21) in DM and 11.58 (7.50–23.25) in prediabetes). But in normoglycamic stroke, SUA levels did not differ in stroke severity at admission (P = 0.066).

Conclusions

Low SUA level (<221 μmol L−1) independently and strongly predicts the short-term poor functional outcome in acute stroke with normoglycaemia other than diabetes or prediabetes.
Appendix
Available only for authorised users
Literature
1.
2.
Weir CJ, Muir SW, Walters MR, et al. Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke. 2003;34:1951–6.CrossRefPubMed
3.
Karagiannis A, Mikhailidis DP, Tziomalos K, et al. Serum uric acid as an independent predictor of early death after acute stroke. Circ J. 2007;71:1120–7.CrossRefPubMed
4.
Newman EJ, Rahman FS, Lees KR, et al. Elevated serum urate concentration independently predicts poor outcome following stroke in patients with diabetes. Diabetes Metab Res Rev. 2006;22:79–82.CrossRefPubMed
5.
Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, et al. Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis. 2013;35:168–74.CrossRefPubMed
6.
Zoppini G, Targher G, Bonora E. The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: a narrative review. J Endocrinol Invest. 2011;34:881–6.CrossRefPubMed
7.
Holme I, Aastveit AH, Hammar N, et al. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2009;266:558–70.CrossRefPubMed
8.
Kramer CK, von Mühlen D, Jassal SK, et al. A prospective study of uric acid by glucose tolerance status and survival: the Rancho Bernardo Study. J Intern Med. 2010;267:561–6.CrossRefPubMed
9.
10.
Chamorro A, Obach V, Cervera A, et al. Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke. 2002;33:1048–52.CrossRefPubMed
11.
Zhang B, Gao C, Yang N, et al. Is elevated SUA associated with a worse outcome in young Chinese patients with acute cerebral ischemic stroke? BMC Neurol. 2010;10:82.CrossRefPubMedPubMedCentral
12.
Amaro S, Urra X, Gómez-Choco M, et al. Uric acid levels are relevant in patients with stroke treated with thrombolysis. Stroke. 2011;42 Suppl 1:S28–32.CrossRefPubMed
13.
Zhang B, Gao C, Hou Q, et al. The potent different risk factors for cerebral infarction in young patients with and without type 2 diabetes: subanalysis of the Young Cerebral Infarction Study (YCIS). Atherosclerosis. 2012;221:215–20.CrossRefPubMed
14.
Miedema I, Uyttenboogaart M, Koch M, et al. Lack of association between serum uric acid levels and outcome in acute ischemic stroke. J Neurol Sci. 2012;319:51–5.CrossRef
15.
Winnard D, Wright C, Jackson G, et al. Gout, diabetes and cardiovascular disease in the Aotearoa New Zealand adult population: co-prevalence and implications for clinical practice. N Z Med J. 2012;126:53–64.
16.
Wu J, Qiu L, Yan WH, et al. Serum gamma-glutamyltransferase and uric acid levels are associated with impaired fasting glucose in adults from Inner Mongolia, China. BMC Public Health. 2013;13:294.CrossRefPubMedCentral
17.
Jia Z, Zhang X, Kang S, Wu Y. Serum uric acid levels and incidence of impaired fasting glucose and type 2 diabetes mellitus: a meta-analysis of cohort studies. Diabetes Res Clin Pract. 2013;101(1):88–96.CrossRef
18.
Shani M, Vinker S, Dinour D, Leiba M, Twig G, Holtzman EJ, Leiba A. High Normal Uric Acid Levels Are Associated with an Increased Risk of Diabetes in Lean, Normoglycemic Healthy Women. J Clin Endocrinol Metab. 2016;101(10):3772–8.CrossRef
19.
Jia Q, Zhao X, Wang C, et al. Diabetes and poor outcomes within 6 months after acute ischemic stroke:the China National Stroke Registry. Stroke. 2011;42:2758–62.
20.
Jia Q, Zheng H, Zhao X, et al. Abnormal glucose regulation in patients with acute stroke across China: prevalence and baseline patient characteristics. Stroke. 2012;43:650–7.CrossRef
21.
Task WHO. Force on Stroke and other Cerebrovascular Disorders. Stroke-1989: Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke. 1989;20:1407–21.CrossRef
22.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29:43–8.
23.
Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program (Letter). Diabetes Care. 1998;21:2191–2.CrossRef
24.
Kamouchi M, Matsuki T, Hata J, et al. Prestroke glycemic control is associated with the functional outcome in acute ischemic stroke: the Fukuoka Stroke Registry. Stroke. 2011;42:2788–94.CrossRef
25.
Theofanidis D. Validation of international stroke scales for use by nurses in Greek settings. Top Stroke Rehabil. 2016:1–8. [Epub ahead of print] PubMed PMID: 27680397.
26.
Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II trial. Stroke. 2008;39:2749–55.CrossRef
27.
Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol. 2005;62:393–7.CrossRef
28.
Menon RK, Mikhailidis DP, Bell JL, Kernoff PB, Dandona P. Warfarin administration increases uric acid concentrations in plasma. Clin Chem. 1986;32(8):1557–9.
29.
Chou P, Lin KC, Lin HY, Tsai ST. Gender differences in the relationships of serum uric acid with fasting serum insulin and plasma glucose in patients without diabetes. J Rheumatol. 2001;28(3):571–6.
30.
Antón FM, García Puig J, Ramos T, González P, Ordás J. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism. 1986;35(4):343–8.CrossRef
31.
Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care. 2002;25:1790–4.CrossRef
32.
Rich MW. Uric acid: is it a risk factor for cardiovascular disease? Am J Cardiol. 2000;85:1018–21.CrossRef
33.
Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003;41:1183–90.CrossRef
34.
Wu H, Jia Q, Liu G, et al. Decreased Uric Acid Levels Correlate with Poor Outcomes in Acute Ischemic Stroke Patients, but Not in Cerebral Hemorrhage Patients. J Stroke Cerebrovasc Dis. 2014;23(3):469–75.CrossRef
35.
Amaro S, Planas AM, Chamorro A. Uric acid administration in patients with acute stroke: a novel approach to neuroprotection. Expert Rev Neurother. 2008;8:259–70.CrossRef
36.
Leinonen JS, Ahonen JP, Lönnrot K, et al. Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke. 2000;31:33–9.CrossRef
37.
Nieto FJ, Iribarren C, Gross MD, et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. 2000;148:131–9.CrossRef
38.
Ames BN, Cathcart R, Schwiers E, et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. ProcNatlAcadSci U S A. 1981;78:6858–62.CrossRef
39.
Davies KJ, Sevanian A, Muakkassah-Kelly SF, et al. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J. 1986;235:747–54.CrossRefPubMedCentral
40.
Zare F, Magnusson M, Bergström T, et al. Uric acid, a nucleic acid degradation product, down-regulates dsRNA-triggered arthritis. J Leukoc Biol. 2006;79:482–8.CrossRef
41.
Patschan D, Patschan S, Gobe GG, et al. Uric acid heralds ischemic tissue injury to mobilize endothelial progenitor cells. J Am SocNephrol. 2007;18:1516–24.
42.
Hink HU, Santanam N, Dikalov S, et al. Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. ArteriosclerThrombVasc Biol. 2002;22:1402–8.CrossRef
43.
Doehner W, Landmesser U. Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options. SeminNephrol. 2011;31:433–40.
44.
George J, Struthers AD. Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress. Vasc Health Risk Manag. 2009;5:265–72.CrossRefPubMedPubMedCentral
45.
Higgins P, Ferguson LD, Walters MR. Xanthine oxidase inhibition for the treatment of stroke disease: a novel therapeutic approach. Expert Rev CardiovascTher. 2011;9:399–401.CrossRef
46.
Brouns R, Wauters A, Van De Vijver G, et al. Decrease in uric acid in acute ischemic stroke correlates with stroke severity, evolution and outcome. ClinChem Lab Med. 2010;48:383–90.
47.
Green HJ, Fraser IG. Differential effects of exercise intensity on serum uric acid concentration. Med Sci Sports Exerc. 1988;20(1):55–9.CrossRefPubMed
Metadata
Title
Lower serum uric acid level strongly predict short-term poor functional outcome in acute stroke with normoglycaemia: a cohort study in China
Authors
Shuolin Wu
Yuesong Pan
Ning Zhang
Wang Yong Jun
Chunxue Wang
On Behalf of the Investigators for the Survey on Abnormal Glucose Regulation in Patients With Acute Stroke Across China (ACROSS-China)
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2017
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-017-0793-6

Other articles of this Issue 1/2017

BMC Neurology 1/2017 Go to the issue

Research article

Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension

Research article

Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP

Case report

Dancing with a seizure, a case report

Case report

Anti-MOG antibody-positive ADEM following infectious mononucleosis due to a primary EBV infection: a case report

Research article

Peginterferon beta-1a improves MRI measures and increases the proportion of patients with no evidence of disease activity in relapsing-remitting multiple sclerosis: 2-year results from the ADVANCE randomized controlled trial

Research article

Association between total-Tau and brain atrophy one year after first-ever stroke